NCT02678676View on ClinicalTrials.gov

An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications

CompletedOBSERVATIONAL
Enrollment

3,599

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No Intervention

Participants who previously received Pioglitazone in the PROactive study (NCT00174993).

OTHER

No Intervention

Participants who previously received pioglitazone-matching placebo in the PROactive study (NCT00174993).

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02678676 - An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications | Biotech Hunter | Biotech Hunter